Publication: The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
item.page.accessRights
Acceso Abierto
item.page.other
item.page.references
Abstract
Background: Retinoblastoma is the most common intraocular cancer worldwide. There is some evidence to suggest that major differences exist in treatment outcomes for children with retinoblastoma from d...
Description
Global Retinoblastoma Study Group: Mattosinho, Clarissa; Teixeira, Luiz; Oscar, Alexander; Veleva, Nevyana; Bouda, Gabrielle; Kabore, Rolande; Philbert, Remezo; Evina, Ted; Nkumbe, Henry; Kamsang, Pius; Muyen, Okwen; Dimaras, Helen; Mallipatna, Ashwin; Hamel, Patrick; Superstein, Rosanne; Paton, Katherine; Strahlendorf, Caron; Komba, Jess; Tyau-Tyau, Harba; Cavieres, Isabel; López, Juan; Oporto, Joaquin; et.al.
item.page.coverage.spatial
item.page.sponsorship
Citation
Global Retinoblastoma Study Group. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022 Aug;10(8):e1128-e1140. doi: 10.1016/S2214-109X(22)00250-9
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026